Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: Implications for the pathogenesis and treatment of bone metastasis

N. Normanno, A. De Luca, D. Aldinucci, M. R. Maiello, M. Mancino, A. D'Antonio, R. De Filippi, A. Pinto

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: Implications for the pathogenesis and treatment of bone metastasis'. Together they form a unique fingerprint.

Medicine & Life Sciences